Capital Investment Advisors, LLC Taysha Gene Therapies, Inc. Transaction History
Capital Investment Advisors, LLC
- $4.37 Billion
- Q2 2024
A detailed history of Capital Investment Advisors, LLC transactions in Taysha Gene Therapies, Inc. stock. As of the latest transaction made, Capital Investment Advisors, LLC holds 10,000 shares of TSHA stock, worth $22,900. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000
Previous 10,000
-0.0%
Holding current value
$22,900
Previous $28,000
21.43%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding TSHA
# of Institutions
107Shares Held
136MCall Options Held
65.4KPut Options Held
41.7K-
Rtw Investments, LP New York, NY18.8MShares$43.1 Million0.7% of portfolio
-
Avoro Capital Advisors LLC New York, NY18.7MShares$42.7 Million0.57% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$26.9 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA10.9MShares$24.9 Million0.37% of portfolio
-
Vr Adviser, LLC New York, NY9MShares$20.6 Million2.21% of portfolio
About Taysha Gene Therapies, Inc.
- Ticker TSHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,359,500
- Market Cap $111M
- Description
- Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...